[Aortic valve disease: Diagnostics and choice of treatment modality]

Area of Science:

• Cardiology
• Cardiac Surgery
• Interventional Cardiology

Background:

• Aortic valve disease, particularly stenosis, is a prevalent acquired condition linked to significant mortality and morbidity.
• The aging population has led to a sharp increase in aortic valve stenosis prevalence.
• Historically, surgical aortic valve replacement was the primary treatment, with conservative management as an alternative.

Purpose of the Study:

• To provide a comprehensive overview of therapeutic options for aortic valve disease.
• To discuss the evolving indications for transcatheter aortic valve implantation (TAVI).
• To guide the decision-making process for optimal treatment modality and timing.

Main Methods:

• Review of current literature and clinical guidelines.
• Analysis of the evolution of transcatheter aortic valve implantation (TAVI).
• Discussion of patient selection criteria for different treatment approaches.

Main Results:

• Transcatheter aortic valve implantation (TAVI) has emerged as a viable alternative to surgical aortic valve replacement.
• The application of TAVI has expanded from high-risk patients to include younger, lower-risk individuals.
• Challenges remain in selecting the optimal therapy and determining the ideal treatment timing.

Conclusions:

• Transcatheter aortic valve implantation (TAVI) represents a significant advancement in managing aortic valve stenosis.
• Clinical decision-making requires careful consideration of patient-specific factors and evolving treatment guidelines.
• Further research and guideline refinement are essential for optimizing patient outcomes.